Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025
Rhea-AI Summary
Castle Biosciences (Nasdaq: CSTL) will release financial results for the third quarter and nine months ended Sept. 30, 2025 after market close on Monday, Nov. 3, 2025.
Management will host a conference call and webcast at 4:30 p.m. Eastern the same day. A live webcast is available at the company investor relations site or via https://events.q4inc.com/attendee/153584002. U.S. phone access is 1-833-470-1428 (access code 735311); international numbers are listed at the provided global numbers link. Attendees are asked to connect at least 10 minutes early. A replay will be available after the call and a brief Q&A will follow management remarks.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, CSTL declined 1.17%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
FRIENDSWOOD, Texas, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2025, after the close of market on Monday, Nov. 3, 2025.
Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.
Conference Call and Webcast Details
A live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/153584002, or via the webcast link on the Investor Relations page of the Company’s website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.
To access the live conference call via phone, please dial 1 833 470 1428 from the United States, at least 10 minutes prior to the start of the call, using the access code 735311. International dial-in numbers are available here: https://www.netroadshow.com/conferencing/global-numbers?confId=89205; please use the same access code above to join the call.
There will be a brief Question and Answer session following management commentary.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
Allison Marshall
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When will Castle Biosciences (CSTL) release Q3 2025 results?
What time is the Castle Biosciences (CSTL) conference call on Nov. 3, 2025?
How can investors join the Castle Biosciences (CSTL) webcast on Nov. 3, 2025?
What is the phone access code for the Castle Biosciences (CSTL) conference call?
Will a replay of the Castle Biosciences (CSTL) Nov. 3, 2025 call be available?
Will Castle Biosciences (CSTL) take questions during the Nov. 3, 2025 call?
